Revvity Inc (RVTY)
104.80
+0.46
(+0.44%)
USD |
NYSE |
May 10, 16:00
104.74
-0.06
(-0.06%)
Pre-Market: 20:00
Revvity Price to Book Value: 1.648 for May 10, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 10, 2024 | 1.648 |
| May 09, 2024 | 1.641 |
| May 08, 2024 | 1.617 |
| May 07, 2024 | 1.622 |
| May 06, 2024 | 1.617 |
| May 03, 2024 | 1.582 |
| May 02, 2024 | 1.591 |
| May 01, 2024 | 1.615 |
| April 30, 2024 | 1.613 |
| April 29, 2024 | 1.653 |
| April 26, 2024 | 1.598 |
| April 25, 2024 | 1.607 |
| April 24, 2024 | 1.616 |
| April 23, 2024 | 1.629 |
| April 22, 2024 | 1.586 |
| April 19, 2024 | 1.587 |
| April 18, 2024 | 1.564 |
| April 17, 2024 | 1.582 |
| April 16, 2024 | 1.578 |
| April 15, 2024 | 1.610 |
| April 12, 2024 | 1.629 |
| April 11, 2024 | 1.708 |
| April 10, 2024 | 1.698 |
| April 09, 2024 | 1.743 |
| April 08, 2024 | 1.675 |
| Date | Value |
|---|---|
| April 05, 2024 | 1.610 |
| April 04, 2024 | 1.600 |
| April 03, 2024 | 1.611 |
| April 02, 2024 | 1.609 |
| April 01, 2024 | 1.625 |
| March 31, 2024 | |
| March 28, 2024 | 1.648 |
| March 27, 2024 | 1.654 |
| March 26, 2024 | 1.623 |
| March 25, 2024 | 1.616 |
| March 22, 2024 | 1.62 |
| March 21, 2024 | 1.649 |
| March 20, 2024 | 1.642 |
| March 19, 2024 | 1.636 |
| March 18, 2024 | 1.634 |
| March 15, 2024 | 1.646 |
| March 14, 2024 | 1.646 |
| March 13, 2024 | 1.694 |
| March 12, 2024 | 1.707 |
| March 11, 2024 | 1.714 |
| March 08, 2024 | 1.715 |
| March 07, 2024 | 1.702 |
| March 06, 2024 | 1.684 |
| March 05, 2024 | 1.679 |
| March 04, 2024 | 1.702 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.316
Minimum
Oct 30 2023
5.582
Maximum
Sep 17 2021
3.112
Average
3.209
Median
Nov 24 2021
Price to Book Value Benchmarks
| Agilent Technologies Inc | 7.092 |
| Bruker Corp | 7.775 |
| Azenta Inc | 1.252 |
| Harvard Bioscience Inc | 2.228 |
| Bionano Genomics Inc | 0.7718 |
Price to Book Value Related Metrics
| PE Ratio | 86.86 |
| PS Ratio | 4.772 |
| Price to Free Cash Flow | 133.95 |
| Price | 104.80 |
| Earnings Yield | 1.15% |
| Market Cap | 12.93B |
| Operating PE Ratio | 48.39 |
| Normalized PE Ratio | 59.36 |